Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562076173> ?p ?o ?g. }
- W2562076173 endingPage "171" @default.
- W2562076173 startingPage "164" @default.
- W2562076173 abstract "Background and aims High plasma LDL-cholesterol (LDL-C) and platelet responses have major pathogenic roles in atherothrombosis. Thus, statins and anti-platelet drugs constitute mainstays in cardiovascular prevention/treatment. However, the role of platelet tissue factor-dependent procoagulant activity (TF-PCA) has remained unexplored in hypercholesterolemia. We aimed to study platelet TF-PCA and its relationship with membrane cholesterol in vitro and in 45 hypercholesterolemic patients (HC-patients) (LDL-C >3.37 mmol/L, 130 mg/dL) and 37 control subjects (LDL-C <3.37 mmol/L). The effect of 1-month administration of 80 mg/day atorvastatin (n = 21) and 20 mg/day rosuvastatin (n = 24) was compared. Methods Platelet TF-PCA was induced by GPIbα activation with VWF-ristocetin. Results Cholesterol-enriched platelets in vitro had augmented aggregation/secretion and platelet FXa generation (1.65-fold increase, p = 0.01). HC-patients had 1.5-, 2.3- and 2.5-fold increases in platelet cholesterol, TF protein and activity, respectively; their platelets had neither hyper-aggregation nor endogenous thrombin generation (ETP). Rosuvastatin, but not atorvastatin, normalized platelet cholesterol, TF protein and FXa generation. It also increased slightly the plasma HDL-C levels, which correlated negatively with TF-PCA. Conclusions Platelets from HC-patients were not hyper-responsive to low concentrations of classical agonists and had normal PRP-ETP, before and after statin administration. However, washed platelets from HC-patients had increased membrane cholesterol, TF protein and TF-PCA. The platelet TF-dependent PCA was specifically expressed after VWF-induced GPIbα activation. Rosuvastatin, but not atorvastatin treatment, normalized the membrane cholesterol, TF protein and TF-PCA in HC-patients, possibly unveiling a new pleiotropic effect of rosuvastatin. Modulation of platelet TF-PCA may become a novel target to prevent/treat atherothrombosis without increasing bleeding risks." @default.
- W2562076173 created "2017-01-06" @default.
- W2562076173 creator A5021822840 @default.
- W2562076173 creator A5022542761 @default.
- W2562076173 creator A5028129601 @default.
- W2562076173 creator A5034503689 @default.
- W2562076173 creator A5052413133 @default.
- W2562076173 creator A5053095040 @default.
- W2562076173 creator A5055869476 @default.
- W2562076173 creator A5057553931 @default.
- W2562076173 creator A5058266891 @default.
- W2562076173 creator A5088030169 @default.
- W2562076173 date "2017-02-01" @default.
- W2562076173 modified "2023-10-18" @default.
- W2562076173 title "Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin" @default.
- W2562076173 cites W1487269619 @default.
- W2562076173 cites W1522513754 @default.
- W2562076173 cites W1539426715 @default.
- W2562076173 cites W173808884 @default.
- W2562076173 cites W1837090086 @default.
- W2562076173 cites W1968144530 @default.
- W2562076173 cites W1979885794 @default.
- W2562076173 cites W1986587470 @default.
- W2562076173 cites W1991245813 @default.
- W2562076173 cites W1996129469 @default.
- W2562076173 cites W2004136399 @default.
- W2562076173 cites W2013737297 @default.
- W2562076173 cites W2016127359 @default.
- W2562076173 cites W2021309429 @default.
- W2562076173 cites W2029342628 @default.
- W2562076173 cites W2033554531 @default.
- W2562076173 cites W2044338450 @default.
- W2562076173 cites W2052507797 @default.
- W2562076173 cites W2056212662 @default.
- W2562076173 cites W2058217708 @default.
- W2562076173 cites W2059050116 @default.
- W2562076173 cites W2061488209 @default.
- W2562076173 cites W2068094239 @default.
- W2562076173 cites W2069539892 @default.
- W2562076173 cites W2082258415 @default.
- W2562076173 cites W2085562583 @default.
- W2562076173 cites W2086668087 @default.
- W2562076173 cites W2097741387 @default.
- W2562076173 cites W2098412834 @default.
- W2562076173 cites W2100896374 @default.
- W2562076173 cites W2104010651 @default.
- W2562076173 cites W2104977728 @default.
- W2562076173 cites W2114991100 @default.
- W2562076173 cites W2122203296 @default.
- W2562076173 cites W2125487451 @default.
- W2562076173 cites W2135744913 @default.
- W2562076173 cites W2145813488 @default.
- W2562076173 cites W2146046969 @default.
- W2562076173 cites W2147613516 @default.
- W2562076173 cites W2153366129 @default.
- W2562076173 cites W2158274535 @default.
- W2562076173 cites W2158834648 @default.
- W2562076173 cites W2159967820 @default.
- W2562076173 cites W2161686469 @default.
- W2562076173 cites W2182627465 @default.
- W2562076173 doi "https://doi.org/10.1016/j.atherosclerosis.2016.12.019" @default.
- W2562076173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28142075" @default.
- W2562076173 hasPublicationYear "2017" @default.
- W2562076173 type Work @default.
- W2562076173 sameAs 2562076173 @default.
- W2562076173 citedByCount "26" @default.
- W2562076173 countsByYear W25620761732017 @default.
- W2562076173 countsByYear W25620761732018 @default.
- W2562076173 countsByYear W25620761732019 @default.
- W2562076173 countsByYear W25620761732020 @default.
- W2562076173 countsByYear W25620761732021 @default.
- W2562076173 countsByYear W25620761732022 @default.
- W2562076173 countsByYear W25620761732023 @default.
- W2562076173 crossrefType "journal-article" @default.
- W2562076173 hasAuthorship W2562076173A5021822840 @default.
- W2562076173 hasAuthorship W2562076173A5022542761 @default.
- W2562076173 hasAuthorship W2562076173A5028129601 @default.
- W2562076173 hasAuthorship W2562076173A5034503689 @default.
- W2562076173 hasAuthorship W2562076173A5052413133 @default.
- W2562076173 hasAuthorship W2562076173A5053095040 @default.
- W2562076173 hasAuthorship W2562076173A5055869476 @default.
- W2562076173 hasAuthorship W2562076173A5057553931 @default.
- W2562076173 hasAuthorship W2562076173A5058266891 @default.
- W2562076173 hasAuthorship W2562076173A5088030169 @default.
- W2562076173 hasConcept C126322002 @default.
- W2562076173 hasConcept C134018914 @default.
- W2562076173 hasConcept C185592680 @default.
- W2562076173 hasConcept C186738567 @default.
- W2562076173 hasConcept C2776057759 @default.
- W2562076173 hasConcept C2776839432 @default.
- W2562076173 hasConcept C2777292125 @default.
- W2562076173 hasConcept C2777482532 @default.
- W2562076173 hasConcept C2778163477 @default.
- W2562076173 hasConcept C2778382381 @default.
- W2562076173 hasConcept C2779394231 @default.
- W2562076173 hasConcept C2780499067 @default.
- W2562076173 hasConcept C3018697912 @default.
- W2562076173 hasConcept C71924100 @default.